SPECIFIC TARGETING OF MITOMYCIN-C TO TUMORS BY ANTIGASTRIC CANCER MONOCLONAL-ANTIBODY

被引:0
作者
LI, S [1 ]
ZHANG, XY [1 ]
CHEN, XT [1 ]
FAN, DM [1 ]
ZHANG, SY [1 ]
CHEN, LJ [1 ]
SHU, YH [1 ]
ZHANG, JL [1 ]
机构
[1] CHINESE ACAD SCI,SHANGHAI INST MAT MED,SHANGHAI 200031,PEOPLES R CHINA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present study, an anti-gastric cancer monoclonal antibody, MGb2, was chosen to prepare antibody-mitomycin C (MMC) conjugate with dextran T-40 as intermediary. Twenty molecules of MMC were introduced into each molecule of antibody while the antigen-binding capacity of the antibody was kept well. The conjugate showed selective cytotoxicity upon human gastric cancer cell line SGC-7901. Radioimmunoimaging and biodistribution studies indicated that after conjugation with MMC via dextran T-40 as intermediary, the tumor localization capacity of the antibody was well retained. When tested in nude mice, inoculated with human gastric carcinoma SGC-7901 in bilateral subrenal capsules, intraperitoneal injection of the conjugate daily for 6 days at a dose of 1 mg/kg gave a tumor inhibitory rate of 68.67%, which was far better than that of free MMC or irrelevant conjugate. No synergetic effect was found in regard to the mixture of MGb2 with MMC.
引用
收藏
页码:358 / 362
页数:5
相关论文
共 8 条
[1]  
BALDWIN RW, 1985, EUR J CANCER CLIN ON, V21, P1231
[2]  
BOGDEN AE, 1978, P S USE ATHYMIC NUDE, P231
[3]  
FAN DM, 1988, CHINESE MED J-PEKING, V101, P488
[4]  
FITZGERALD DJ, 1987, CANCER RES, V47, P1407
[5]  
LI S, 1990, ACTA PHARM SINIC, V11, P367
[6]  
LI S, 1989, CHIN J PHARM TOXICOL, V3, P81
[7]   PRODUCTION OF A MONOCLONAL ANTIBODY-MITOMYCIN-C CONJUGATE, UTILIZING DEXTRAN T-40, AND ITS BIOLOGICAL-ACTIVITY [J].
MANABE, Y ;
TSUBOTA, T ;
HARUTA, Y ;
KATAOKA, K ;
OKAZAKI, M ;
HAISA, S ;
NAKAMURA, K ;
KIMURA, I .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (02) :289-291
[8]  
ZHANG SY, 1989, ACTA PHARM SINIC, V10, P450